Cas:544-17-2 Calcium diformate manufacturer & supplier

We serve Chemical Name:Calcium diformate CAS:544-17-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Calcium diformate

Chemical Name:Calcium diformate
CAS.NO:544-17-2
Synonyms:calcium formiate;Formic acid, calcium salt (2:1);Berylliumformate (6CI,7CI);Formic acid beryllium salt;beryllium formiate;formic acid,calcium formate;Berylliumformiat;Ameisensaeure,Berylliumformiat;MFCD00036108;EINECS 208-863-7;Calciumformiat;Ameisensaeure,Calciumformiat;Calcium diformate;Formic acid,berylliumsalt (8CI,9CI);Beryllium formate;formic acid,beryllium formate
Molecular Formula:C2H2CaO4
Molecular Weight:130.113
HS Code:2915120000

Physical and Chemical Properties:
Melting point:300 °C
Boiling point:100.6ºC at 760mmHg
Density:2,02 g/cm3
Index of Refraction:
PSA:52.60000
Exact Mass:129.957901
LogP:0.51920

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like calcium formiate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,formic acid,beryllium formate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00036108 Use and application,Beryllium formate technical grade,usp/ep/jp grade.


Related News: Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted. Calcium diformate manufacturer The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. Calcium diformate supplier Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. Calcium diformate vendor Of the nearly 4,000 Black women and more than 25,000 white women included in the study, there was no statistically significant difference in breast cancer-related genetic mutations. They were found in 5.65% of Black women and nearly 5.1% of white women. Calcium diformate factory The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.